G Antonelli|F Dianzani - JoVE Visualize

Showing results (51-60 of 264) with videos related to

Pageof 27

Sort By:

AIDS (London, England)|February 24, 2001

Changes in host cell molecules acquired by circulating HIV-1 in patients treated with highly active antiretroviral therapy and interleukin-2I Abbate, F Dianzani, O Turriziani, et al.

Journal of Biological Regulators and Homeostatic Agents|April 1, 1994

Resistance to recombinant alpha interferon therapy in idiopathic mixed cryoglobulinemia: reinduction of remission by natural alpha interferon both in antibody-positive and -negative patientsM Casato, G Antonelli, F Maggi, et al.

Journal of the Neurological Sciences|October 20, 1999

Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1bG Antonelli, E Simeoni, F Bagnato, et al.

Hepatology (Baltimore, Md.)|March 1, 1995

Breakthrough during recombinant interferon alfa therapy in patients with chronic hepatitis C virus infection: prevalence, etiology, and managementL Roffi, G C Mels, G Antonelli, et al.

Antiviral Research|July 1, 1994

The interferons: a biological system with therapeutic potential in viral infectionsS Baron, F Dianzani

Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1987

The Italian National Research Council and hospital infectionsF Dianzani, A Zampieri

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 20, 1999

Antigenic characterization of recombinant, lymphoblastoid, and leukocyte IFN-alpha by monoclonal antibodiesG C Viscomi, G Antonelli, C Bruno, et al.

AIDS Research and Human Retroviruses|January 10, 2002

Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapyE Riva, M Pistello, P Narciso, et al.

Clinical and Experimental Immunology|June 1, 1996

Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN-alpha2 therapyG Antonelli, G Giannelli, M Currenti, et al.

Annali Di Igiene : Medicina Preventiva E Di Comunita|May 1, 1989

[Acid-labile alpha interferon produced by peripheral blood mononuclear cells stimulated by cells infected by HIV]F Dianzani, M R Capobianchi, F De Marco, et al.

Pageof 27

Showing results (51-60 of 264) with videos related to

Sort By:

Pageof 27

AIDS (London, England)|February 24, 2001

Changes in host cell molecules acquired by circulating HIV-1 in patients treated with highly active antiretroviral therapy and interleukin-2I Abbate, F Dianzani, O Turriziani, et al.

Journal of Biological Regulators and Homeostatic Agents|April 1, 1994

Resistance to recombinant alpha interferon therapy in idiopathic mixed cryoglobulinemia: reinduction of remission by natural alpha interferon both in antibody-positive and -negative patientsM Casato, G Antonelli, F Maggi, et al.

Journal of the Neurological Sciences|October 20, 1999

Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1bG Antonelli, E Simeoni, F Bagnato, et al.

Hepatology (Baltimore, Md.)|March 1, 1995

Breakthrough during recombinant interferon alfa therapy in patients with chronic hepatitis C virus infection: prevalence, etiology, and managementL Roffi, G C Mels, G Antonelli, et al.

Antiviral Research|July 1, 1994

The interferons: a biological system with therapeutic potential in viral infectionsS Baron, F Dianzani

Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1987

The Italian National Research Council and hospital infectionsF Dianzani, A Zampieri

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 20, 1999

Antigenic characterization of recombinant, lymphoblastoid, and leukocyte IFN-alpha by monoclonal antibodiesG C Viscomi, G Antonelli, C Bruno, et al.

AIDS Research and Human Retroviruses|January 10, 2002

Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapyE Riva, M Pistello, P Narciso, et al.

Clinical and Experimental Immunology|June 1, 1996

Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN-alpha2 therapyG Antonelli, G Giannelli, M Currenti, et al.

Annali Di Igiene : Medicina Preventiva E Di Comunita|May 1, 1989

[Acid-labile alpha interferon produced by peripheral blood mononuclear cells stimulated by cells infected by HIV]F Dianzani, M R Capobianchi, F De Marco, et al.

Pageof 27